3 completed, 1 active not recruiting. 4 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 4 | Completed 3, Active not recruiting 1 |
| Phase 2 | 1 | Completed 1 |
Follow Parasitic Disease: new trials by email Literature Review of Parasitic Disease trials Research Report on Parasitic Disease
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study to Assess the Safety and Effectiveness of Two Experimental Malaria Vaccines RH5.1 and/or RH5.2-VLP with Matrix-M - Malaria, Malaria,Falciparum | Phase 1 / Phase 2 | Completed | University of Oxford | 41 | 2023-08-18 | 2026-07-20 |
| A Study to Compare Two Dosing Regimens for a New Malaria Vaccine Matrix M with RH5.1 - Malaria, Malaria,Falciparum | Phase 1 | Active not recruiting | University of Oxford | 24 | 2023-06-06 | 2024-10-04 |
| Pyronaridine in Healthy Adult Participants Infected With Blood Stage Malaria Pyronaridine, P. falciparum IBSM infection - Malaria,Falciparum, Malaria | Phase 1 | Completed | Medicines for Malaria Venture | 10 | 2022-04-04 | 2025-04-16 |
| Study in Blood Stage Malaria Infection After DVI of Cryopreserved P. Falciparum (NF54 Strain) Sporozoites Artemether-Lumefantrine 20 Mg-120 Mg Oral Tablet, PfSPZ-DVI Challenge - Malaria,Falciparum, Parasitemia | Phase 1 | Completed | Medicines for Malaria Venture | 16 | 2020-02-19 | 2021-09-05 |
Malaria (4) · Malaria, Falciparum (4) · Parasitic Diseases (4) · Protozoan Infections (3) · Infections (2) · Parasitemia (2) · Vector Borne Diseases (2)
Mosquito-Borne Diseases (4) · Infections (2) · Inflammation (2) · Pathologic Processes (2) · Pathological Conditions, Signs and Symptoms (2) · Sepsis (2) · Systemic Inflammatory Response Syndrome (2) · Vector Borne Diseases (2) · Protozoan Infections (1)
Matrix-M (2) · Artemether, Lumefantrine Drug Combination (1) · pyronaridine (1)
Medicines for Malaria Venture (2) · University of Oxford (2)
United Kingdom (2) · Australia (1) · Belgium (1)
Angela Minassian, Dr (1) · Farouk Chughlay, MD (1)
2019 (1)